<DOC>
	<DOC>NCT02232815</DOC>
	<brief_summary>This study will examine outcomes for patients treated by planned culotte stenting and compare outcomes with 2 different stent platforms, the next generation Synergy II and the Xience Xpedition DES platforms.</brief_summary>
	<brief_title>CELTIC Bifurcation Study</brief_title>
	<detailed_description />
	<criteria>Male or female patient &gt;18 years old Females of childbearing potential with a negative pregnancy test Coronary artery disease requiring revascularization that is amenable to PCI Medina 1,1,1 bifurcation lesion [13] with &gt;70% lesion in both the main vessel and the side branch by visual assessment Main branch and side branch â‰¥ 2.5mm in diameter by visual assessment Both vessels require stenting in the opinion of the operator Acute myocardial infarction with ongoing STelevation Cardiogenic shock Lesion involves the left main coronary artery Lesion involves bypass graft Plan to treat &gt;1 other coronary vessel at the time of inclusion Chronic total occlusion of any target vessel Left ventricular ejection fraction &lt;20% Requirement for ongoing haemodialysis Lifeexpectancy limited to &lt;12 months due to comorbid condition Known allergy to Aspirin Known allergy to Clopidorel and Prasugrel and Ticagrelor Known allergy to stent drug elutant Known allergy to any other component of either the Synergy II or Xience Xpedition stents systems Ongoing participation in another investigational device or drug study Inability to provide informed consent</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2016</verification_date>
</DOC>